Waters Corporation (WAT) PEG Ratio: 75.62
Is Waters Corporation’s PEG ratio high or low?
Waters Corporation's PEG ratio of 75.62 is 175% above its 4-year average of 27.51, near the high end of its 4-year range (0.98–75.62).
In line with its 12-month average of 75.62.
WAT PEG Ratio Chart
WAT Average PEG Ratio Chart
WAT Current vs Average PEG Ratio Chart
WAT PEG Ratio Metrics
PEG RATIO
75.62
PEG RATIO AVG TTM
75.62
PEG RATIO AVG 3Y
40.78
PEG RATIO AVG 5Y
27.51
PEG RATIO AVG 10Y
12.59
PEG RATIO AVG 15Y
12.86
PEG RATIO AVG 20Y
9.95
CURRENT VS TTM AVG
+0.00%
CURRENT VS 3Y AVG
+85.43%
CURRENT VS 5Y AVG
+174.85%
CURRENT VS 10Y AVG
+500.43%
CURRENT VS 15Y AVG
+487.98%
CURRENT VS 20Y AVG
+660.00%
WAT Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $23.21B | 75.62 | 75.62 | 40.78 | 27.51 |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 8.96 | 5.67 | 4.53 | 3.90 |
| BioNTech SE (BNTX) | $22.39B | N/A | 0.23 | 0.12 | 0.12 |
| Veeva Systems Inc. (VEEV) | $26.31B | 1.42 | 1.47 | 5.64 | 5.88 |
| Moderna, Inc. (MRNA) | $18.71B | N/A | 0.18 | 0.14 | 0.14 |
| DexCom, Inc. (DXCM) | $28.92B | 0.66 | 19.99 | 10.91 | 8.76 |
| Biogen Inc. (BIIB) | $28.94B | N/A | 0.34 | 0.24 | 0.23 |
| Hologic, Inc. (HOLX) | $16.97B | N/A | 0.30 | 0.22 | 1.95 |
| IQVIA Holdings Inc. (IQV) | $30.08B | 6.34 | 8.50 | 5.12 | 3.87 |
| Medline Inc. (MDLN) | $30.90B | N/A | 0.07 | 0.07 | 0.07 |
Growth-Adjusted Valuation
PEG Ratio
75.62
P/E Ratio
46.1
Waters Corporation PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation PEG Ratio FAQ
- What is the PEG ratio for Waters Corporation (WAT)?
- The PEG ratio for WAT stock is 75.62.
- Is Waters Corporation's PEG ratio high or low?
- Waters Corporation's PEG ratio of 75.62 is 175% above its 4-year average of 27.51, near the high end of its 4-year range (0.98–75.62).
- What is the TTM average PEG ratio for Waters Corporation (WAT)?
- The TTM average PEG ratio for WAT stock is 75.62.
- What is the 3Y average PEG ratio for Waters Corporation (WAT)?
- The 3Y average PEG ratio for WAT stock is 40.78.
- What is the 5Y average PEG ratio for Waters Corporation (WAT)?
- The 5Y average PEG ratio for WAT stock is 27.51.
- What is the 10Y average PEG ratio for Waters Corporation (WAT)?
- The 10Y average PEG ratio for WAT stock is 12.59.
- What is the 15Y average PEG ratio for Waters Corporation (WAT)?
- The 15Y average PEG ratio for WAT stock is 12.86.
- What is the 20Y average PEG ratio for Waters Corporation (WAT)?
- The 20Y average PEG ratio for WAT stock is 9.95.
Waters Corporation PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 75.62 |
| 2022-12-31 | 5.94 |
| 2021-12-31 | 0.98 |
| 2019-12-31 | 1.96 |
| 2018-12-31 | 0.01 |
| 2016-12-31 | 1.56 |
| 2015-12-31 | 2.09 |
| 2013-12-31 | 49.83 |
| 2012-12-31 | 1.65 |
| 2011-12-31 | 1.00 |
| 2010-12-31 | 0.83 |
| 2009-12-31 | 4.97 |
| 2008-12-31 | 0.52 |
| 2007-12-31 | 1.26 |
| 2006-12-31 | 1.03 |
| 2004-12-31 | 0.72 |
| 2003-12-31 | 1.04 |
| 2002-12-31 | 0.68 |
| 2000-12-31 | 4.84 |
| 1999-12-31 | 0.43 |
| 1996-12-31 | 1.27 |
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra